Potential of Lung Surfactant Proteins, SP-A and SP-D, and Mannan Binding Lectin for Therapy and Genetic Predisposition to Allergic and Invasive Aspergillosis

Publisher： Bentham Science Publishers

E-ISSN： 2212-2710|1|3|183-187

ISSN： 1872-213X

Source： Recent Patents on Inflammation & Allergy Drug Discovery, Vol.1, Iss.3, 2007-11, pp. : 183-187

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dehydroepiandrosterone in Therapy of Allergic Diseases

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 3, Iss. 3, 2009-11 ,pp. : 211-213

Bentham Science Publishers

Access to resources Recommend Favorite

Potential of Nanocarriers in Genetic Immunization

By  

Recent Patents on Drug Delivery & Formulation, Vol. 2, Iss. 1, 2008-01 ,pp. : 68-82

Bentham Science Publishers

Access to resources Recommend Favorite

Daclizumab: A Potential Asthma Therapy?

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 4, Iss. 3, 2010-11 ,pp. : 214-221

Bentham Science Publishers

Access to resources Recommend Favorite

Surfactant Therapy of Pulmonary Conditions Excluding those with Primary Surfactant Deficiency and Bronchoscopy as Delivery Method: An Overview of Russian Patents and Publications

By  

Recent Patents on Drug Delivery & Formulation, Vol. 7, Iss. 2, 2013-08 ,pp. : 134-137

Bentham Science Publishers

Access to resources Recommend Favorite

Surfactant Protein D in Chornic Obstructive Pulmonary Disease (COPD)

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 8, Iss. 1, 2014-01 ,pp. : 42-47

Bentham Science Publishers

Access to resources Recommend Favorite